Berdazimer sodium clinical trials

Studies by the year they started

20 studies that test it; most in 2016 (5)

Who runs them

Industry 20 · Other 0

Novan, Inc. (20)

Studies

Open first, then newest update. How each study uses berdazimer sodium is read from its arms, and is right about nine times in ten.

Testing it · 20

• P3 Study Comparing Once Daily SB204 and Vehicle Gel in AcneCompletedPhase 3Novan, Inc.NCT02667444Written as SB204 4%
• P3 Study in Acne Comparing Once Daily SB204 and VehicleCompletedPhase 3Novan, Inc.NCT02672332Written as SB204 4%
• P2 Multi-center Study of SB204 Gel in the Treatment of Acne VulgarisCompletedPhase 2Novan, Inc.NCT02242760Written as SB204 2%
• P3 Long Term Safety Study of Once Daily SB204 in AcneCompletedPhase 3Novan, Inc.NCT02798120Written as SB204 4%
• A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum ContagiosumCompletedPhase 2Novan, Inc.NCT03436615Written as SB206 4%
• Topical NVN1000 for the Treatment of External Genital and Perianal WartsCompletedPhase 2Novan, Inc.NCT02462187Written as NVN1000 8% Gel
• A Phase 3 Efficacy & Safety of SB206 & Vehicle Gel for the Treatment of MCCompletedPhase 3Novan, Inc.NCT03927703Written as SB206 12%
• A Phase 3 Molluscum Contagiosum Efficacy and Safety StudyCompletedPhase 3Novan, Inc.NCT04535531Written as SB206 10.3% berdazimer
• A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)CompletedPhase 3Novan, Inc.NCT03927716Written as SB206 12%
• Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy VolunteersCompletedPhase 1Novan, Inc.NCT01694810Written as 2% NVN1000 Topical Gel
• SB208 for the Treatment of Tinea PedisCompletedPhase 2Novan, Inc.NCT02860052Written as SB208 2%
• A Phase 1 Study Assessing Local Cutaneous Effects of SB204CompletedPhase 1Novan, Inc.NCT02250430Written as SB204
• A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 GelCompletedPhase 1Novan, Inc.NCT01844739Written as NVN1000 4% Gel
• A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204CompletedPhase 1Novan, Inc.NCT02581072Written as SB204 4%
• A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With AcneCompletedPhase 2Novan, Inc.NCT01844752Written as NVN1000 1% Gel
• Study of NVN1000 Topical Gel and Topical Gel Vehicle in the Treatment of Moderate to Severe Acne VulgarisCompletedPhase 1/2Novan, Inc.NCT01556698Written as NVN1000
• Pharmacokinetics of Topical SB204 in Adolescents With Acne VulgarisCompletedPhase 1Novan, Inc.NCT02801903Written as SB204 4%
• A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic DermatitisCompletedPhase 1Novan, Inc.NCT03431610Written as SB414 2%
• A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in PsoriasisCompletedPhase 1Novan, Inc.NCT03445013Written as SB414 6%
• A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne VulgarisCompletedPhase 1Novan, Inc.NCT02164084Written as SB204

Codes

What other systems call berdazimer sodium · ClinicalTrials.gg INT001374

• MeSH (NLM) C000709171berdazimer sodiumOne source NLM
• UNII (FDA) ORT9SID4QYBERDAZIMER SODIUMConfirmed FDA, NLM
• NCI Thesaurus C174810Berdazimer SodiumOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.